{
  "title": "What Next TBD: The AstraZeneca Saga",
  "description": "Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. \n\nBy all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?\n\nGuest: \n \nPeter Aldhous, science reporter at Buzzfeed News\n\nHost\nLizzie O’Leary\n \nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "pubDate": "Fri, 26 Mar 2021 10:00:00 -0000",
  "itunes:title": "What Next TBD: The AstraZeneca Saga",
  "itunes:episodeType": "full",
  "itunes:author": "Slate Podcasts",
  "itunes:image": "",
  "itunes:subtitle": "By all accounts, Oxford and AstraZeneca made a good vaccine. So why has the path to approval been so painful?",
  "itunes:summary": "Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. \n\nBy all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?\n\nGuest: \n \nPeter Aldhous, science reporter at Buzzfeed News\n\nHost\nLizzie O’Leary\n \nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "content:encoded": "<p>Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. </p><p><br></p><p>By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?</p><p><br></p><p><strong>Guest: </strong></p><p> </p><p><a href=\"https://twitter.com/paldhous?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">Peter Aldhous</a>, science reporter at Buzzfeed News</p><p><br></p><p><strong>Host</strong></p><p>Lizzie O’Leary</p><p> </p><p> </p><p>Learn more about your ad choices. Visit <a href=\"https://megaphone.fm/adchoices\">megaphone.fm/adchoices</a></p>",
  "itunes:duration": 1609,
  "guid": "2f5a081a-8dac-11eb-b32a-474cfc139042",
  "enclosure": ""
}